Saira Sundus is an Endocrinology/Metabolic physician affiliated with Wayne State University. OpenAlex indexes 9 publications with 454 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5040 Villa Linde Pkwy
Flint, MI 485323445
Telephone
810-230-0788Provider last certified this registry record 18 Jan 2023.
Industry payments
48 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year202512 payments
- Amgen Inc.Program year202529 payments
- Corcept TherapeuticsProgram year202518 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
82.2%GLP-1 receptor agonist26.8%Ozempic40%Mounjaro30%Trulicity29%Victoza 3-Pak1%Part D<11 patientsInsulin Analog23%Lantus Solostar39%Novolog Flexpen13%Humalog Kwikpen U-10012%Basaglar Kwikpen U-1007%Tresiba Flextouch U-2007%Tresiba Flextouch U-1004%Toujeo Max Solostar3%Humalog3%Fiasp Flextouch2%Novolog2%Insulin Aspart Flexpen2%Levemir Flexpen2%Toujeo Solostar2%Lantus1%Insulin Lispro Kwikpen U-1001%Humalog Kwikpen U-2001%Part D<11 patients+ 10 more classes in this area
Hormonal (systemic)
12.6%l-Thyroxine9.6%Levothyroxine Sodium100%Part D≥161 patientsThyroid Hormone Synthesis Inhibitor1.5%Methimazole100%Part D≥25 patients+ 4 more classes in this area
Cardiovascular
2.1%Statin1.4%Atorvastatin Calcium53%Rosuvastatin Calcium23%Simvastatin23%Part D<11 patientsACE inhibitor0.4%Lisinopril100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- SGLT2 inhibitors and sleep apnea; how helpful are the medications: A meta-analysis
Endocrine and Metabolic Science
2021 - Triple versus dual inhaler therapy in moderate‐to‐severe COPD: A systematic review and meta‐analysis of randomized controlled trials
The Clinical Respiratory Journal
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Pranatharthi Chandrasekar, MD
Wayne State University
Bret Hughes, MD
Wayne State University
Mark Juzych, MD, MHSA
Wayne State University
Lubina Arjyal, MD
Wayne State University
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”